Results
|
1.
|
Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma. [electronic resource] by
- Propper, David
- Jones, Keith
- Anthoney, D Alan
- Mansoor, Wasat
- Ford, Daniel
- Eatock, Martin
- Agarwal, Roshan
- Inatani, Michiyasu
- Saito, Tomohisa
- Abe, Masaichi
- Evans, T R Jeffry
Producer: 20170926
In:
BMC cancer vol. 16
Availability: No items available.
|
|
2.
|
|
|
3.
|
A first in man, phase I dose-escalation study of PHA-793887, an inhibitor of multiple cyclin-dependent kinases (CDK2, 1 and 4) reveals unexpected hepatotoxicity in patients with solid tumors. [electronic resource] by
- Massard, Christophe
- Soria, Jean-Charles
- Anthoney, D Alan
- Proctor, A
- Scaburri, Angela
- Pacciarini, Maria Adele
- Laffranchi, Bernard
- Pellizzoni, Cinzia
- Kroemer, Guido
- Armand, Jean-Pierre
- Balheda, Rastilav
- Twelves, Christopher J
Producer: 20110823
In:
Cell cycle (Georgetown, Tex.) vol. 10
Availability: No items available.
|
|
4.
|
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma. [electronic resource] by
- Thomas, Anne
- Virdee, Pradeep S
- Eatock, Martin
- Lord, Simon R
- Falk, Stephen
- Anthoney, D Alan
- Turkington, Richard C
- Goff, Matthew
- Elhussein, Leena
- Collins, Linda
- Love, Sharon
- Moschandreas, Joanna
- Middleton, Mark R
Producer: 20200629
In:
European journal of cancer (Oxford, England : 1990) vol. 124
Availability: No items available.
|
|
5.
|
Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses. [electronic resource] by
- Anthoney, D Alan
- Naik, Jay
- Macpherson, Iain R J
- Crawford, Donna
- Hartley, John M
- Hartley, Janet A
- Saito, Tomohisa
- Abe, Masaichi
- Jones, Keith
- Miwa, Masanori
- Twelves, Christopher
- Evans, T R J
Producer: 20130523
In:
BMC cancer vol. 12
Availability: No items available.
|
|
6.
|
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. [electronic resource] by
- Cook, Natalie
- Basu, Bristi
- Smith, Donna-Michelle
- Gopinathan, Aarthi
- Evans, Jeffry
- Steward, William P
- Palmer, Daniel
- Propper, David
- Venugopal, Balaji
- Hategan, Mirela
- Anthoney, D Alan
- Hampson, Lisa V
- Nebozhyn, Michael
- Tuveson, David
- Farmer-Hall, Hayley
- Turner, Helen
- McLeod, Robert
- Halford, Sarah
- Jodrell, Duncan
Producer: 20190415
In:
British journal of cancer vol. 118
Availability: No items available.
|
|
7.
|
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial. [electronic resource] by
- Valle, Juan W
- Wasan, Harpreet
- Lopes, Andre
- Backen, Alison C
- Palmer, Daniel H
- Morris, Karen
- Duggan, Marian
- Cunningham, David
- Anthoney, D Alan
- Corrie, Pippa
- Madhusudan, Srinivasan
- Maraveyas, Anthony
- Ross, Paul J
- Waters, Justin S
- Steward, Will P
- Rees, Charlotte
- Beare, Sandy
- Dive, Caroline
- Bridgewater, John A
Producer: 20151027
In:
The Lancet. Oncology vol. 16
Availability: No items available.
|